Literature DB >> 29997216

Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.

Maud Mavigner1, Jakob Habib1, Claire Deleage2, Elias Rosen3, Cameron Mattingly1, Katherine Bricker1, Angela Kashuba3, Franck Amblard1, Raymond F Schinazi1, Benton Lawson4, Thomas H Vanderford4, Sherrie Jean4, Joyce Cohen4, Colleen McGary4, Mirko Paiardini4, Matthew P Wood5, Donald L Sodora5, Guido Silvestri4, Jacob Estes2,6, Ann Chahroudi7,4,8.   

Abstract

Worldwide, nearly two million children are infected with human immunodeficiency virus (HIV), with breastfeeding accounting for the majority of contemporary HIV transmissions. Antiretroviral therapy (ART) has reduced HIV-related morbidity and mortality but is not curative. The main barrier to a cure is persistence of latent HIV in long-lived reservoirs. However, our understanding of the cellular and anatomic sources of the HIV reservoir during infancy and childhood is limited. Here, we developed a pediatric model of ART suppression in orally simian immunodeficiency virus (SIV)-infected rhesus macaque (RM) infants, with measurement of virus persistence in blood and tissues after 6 to 9 months of ART. Cross-sectional analyses were conducted to compare SIV RNA and DNA levels in adult and infant RMs naive to treatment and on ART. We demonstrate efficient viral suppression following ART initiation in SIV-infected RM infants with sustained undetectable plasma viral loads in the setting of heterogeneous penetration of ART into lymphoid and gastrointestinal tissues and low drug levels in the brain. We further show reduction in SIV RNA and DNA on ART in lymphoid tissues of both infant and adult RMs but stable (albeit low) levels of SIV RNA and DNA in the brains of viremic and ART-suppressed infants. Finally, we report a large contribution of naive CD4+ T cells to the total CD4 reservoir of SIV in blood and lymph nodes of ART-suppressed RM infants that differs from what we show in adults. These results reveal important aspects of HIV/SIV persistence in infants and provide insight into strategic targets for cure interventions in a pediatric population.IMPORTANCE While antiretroviral therapy (ART) can reduce HIV replication, the virus cannot be eradicated from an infected individual, and our incomplete understanding of HIV persistence in reservoirs greatly complicates the generation of a cure for HIV infection. Given the immaturity of the infant immune system, it is critically important to study HIV reservoirs specifically in this population. Here, we established a pediatric animal model to simulate breastfeeding transmission and study SIV reservoirs in rhesus macaque (RM) infants. Our study demonstrates that ART can be safely administered to infant RMs for prolonged periods and that it efficiently controls viral replication in this model. SIV persistence was shown in blood and tissues, with similar anatomic distributions of SIV reservoirs in infant and adult RMs. However, in the peripheral blood and lymph nodes, a greater contribution of the naive CD4+ T cells to the SIV reservoir was observed in infants than in adults.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  SIV; antiretroviral therapy; infants; rhesus macaques

Mesh:

Year:  2018        PMID: 29997216      PMCID: PMC6146711          DOI: 10.1128/JVI.00562-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Authors:  D A Eckstein; M L Penn; Y D Korin; D D Scripture-Adams; J A Zack; J F Kreisberg; M Roederer; M P Sherman; P S Chin; M A Goldsmith
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

Review 2.  Challenges in the Elimination of Pediatric HIV-1 Infection.

Authors:  Katherine Luzuriaga; Lynne M Mofenson
Journal:  N Engl J Med       Date:  2016-02-25       Impact factor: 91.245

3.  Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.

Authors:  Ellen Gould Chadwick; Jorge Pinto; Ram Yogev; Carmelita G Alvero; Michael D Hughes; Paul Palumbo; Brian Robbins; Rohan Hazra; Leslie Serchuck; Barbara E Heckman; Lynette Purdue; Renee Browning; Katherine Luzuriaga; John Rodman; Edmund Capparelli
Journal:  Pediatr Infect Dis J       Date:  2009-03       Impact factor: 2.129

4.  Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Gregory Q Del Prete; Jeremy Smedley; Rhonda Macallister; Gregg S Jones; Bei Li; Jillian Hattersley; Jim Zheng; Michael Piatak; Brandon F Keele; Joseph Hesselgesser; Romas Geleziunas; Jeffrey D Lifson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-09       Impact factor: 2.205

5.  Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaques.

Authors:  Diane L Bolton; Jacob T Minang; Matthew T Trivett; Kaimei Song; Jennifer J Tuscher; Yuan Li; Michael Piatak; David O'Connor; Jeffrey D Lifson; Mario Roederer; Claes Ohlen
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

7.  Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children.

Authors:  Laurene H Wang; Andrew A Wiznia; Mobeen H Rathore; Gregory E Chittick; Saroj S Bakshi; Patricia J Emmanuel; Patricia M Flynn
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

8.  Defining total-body AIDS-virus burden with implications for curative strategies.

Authors:  Jacob D Estes; Cissy Kityo; Francis Ssali; Louise Swainson; Krystelle Nganou Makamdop; Gregory Q Del Prete; Steven G Deeks; Paul A Luciw; Jeffrey G Chipman; Gregory J Beilman; Torfi Hoskuldsson; Alexander Khoruts; Jodi Anderson; Claire Deleage; Jacob Jasurda; Thomas E Schmidt; Michael Hafertepe; Samuel P Callisto; Hope Pearson; Thomas Reimann; Jared Schuster; Jordan Schoephoerster; Peter Southern; Katherine Perkey; Liang Shang; Stephen W Wietgrefe; Courtney V Fletcher; Jeffrey D Lifson; Daniel C Douek; Joseph M McCune; Ashley T Haase; Timothy W Schacker
Journal:  Nat Med       Date:  2017-10-02       Impact factor: 53.440

9.  Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques.

Authors:  Ann Chahroudi; Emily Cartwright; S Thera Lee; Maud Mavigner; Diane G Carnathan; Benton Lawson; Paul M Carnathan; Tayebeh Hashempoor; Megan K Murphy; Tracy Meeker; Stephanie Ehnert; Christopher Souder; James G Else; Joyce Cohen; Ronald G Collman; Thomas H Vanderford; Sallie R Permar; Cynthia A Derdeyn; Francois Villinger; Guido Silvestri
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

10.  Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses.

Authors:  Katherine S Wetzel; Yanjie Yi; Anjana Yadav; Anya M Bauer; Ezekiel A Bello; Dino C Romero; Frederic Bibollet-Ruche; Beatrice H Hahn; Mirko Paiardini; Guido Silvestri; Martine Peeters; Ronald G Collman
Journal:  PLoS Pathog       Date:  2018-04-16       Impact factor: 6.823

View more
  30 in total

Review 1.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

2.  Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy.

Authors:  Guangming Li; Zheng Zhang; Natalia Reszka-Blanco; Feng Li; Liqun Chi; Jianping Ma; Jerry Jeffrey; Liang Cheng; Lishan Su
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs.

Authors:  Aaron S Devanathan; Jason R Pirone; Ramesh Akkina; Leila Remling-Mulder; Paul Luciw; Lourdes Adamson; J Victor Garcia; Martina Kovarova; Nicole R White; Amanda P Schauer; Kimberly Blake; Craig Sykes; Erin M Burgunder; Nithya Srinivas; Elias P Rosen; Angela D M Kashuba
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.

Authors:  Samuel Long; Christine M Fennessey; Laura Newman; Carolyn Reid; Sean P O'Brien; Yuan Li; Gregory Q Del Prete; Jeffrey D Lifson; Robert J Gorelick; Brandon F Keele
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1.

Authors:  Jennifer M Zerbato; Deborah K McMahon; Michelle D Sobolewski; John W Mellors; Nicolas Sluis-Cremer
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

6.  More than a Gender Issue: Testis as a Distinctive HIV Reservoir and Its Implication for Viral Eradication.

Authors:  Jean-Pierre Routy; Franck P Dupuy; John Lin; Stéphane Isnard
Journal:  Methods Mol Biol       Date:  2022

7.  Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.

Authors:  Anya M Bauer; Widade Ziani; Emily Lindemuth; Leticia Kuri-Cervantes; Hui Li; Fang-Hua Lee; Meagan Watkins; Wenge Ding; Huanbin Xu; Ronald Veazey; Katharine J Bar
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

8.  Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.

Authors:  Pilar Garcia-Broncano; Shivaali Maddali; Kevin B Einkauf; Chenyang Jiang; Ce Gao; Joshua Chevalier; Fatema Z Chowdhury; Kenneth Maswabi; Gbolahan Ajibola; Sikhulile Moyo; Terence Mohammed; Thabani Ncube; Joseph Makhema; Patrick Jean-Philippe; Xu G Yu; Kathleen M Powis; Shahin Lockman; Daniel R Kuritzkes; Roger Shapiro; Mathias Lichterfeld
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

9.  Next-generation Viral RNA/DNA in situ Hybridization Applications in Human Immunodeficiency Virus/Simian Immunodeficiency Virus Research.

Authors:  Catherine Brands; David Morcock; Jacob Estes; Claire Deleage
Journal:  J Vis Exp       Date:  2020-06-17       Impact factor: 1.355

Review 10.  Non-human Primate Models to Investigate Mechanisms of Infection-Associated Fetal and Pediatric Injury, Teratogenesis and Stillbirth.

Authors:  Miranda Li; Alyssa Brokaw; Anna M Furuta; Brahm Coler; Veronica Obregon-Perko; Ann Chahroudi; Hsuan-Yuan Wang; Sallie R Permar; Charlotte E Hotchkiss; Thaddeus G Golos; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.